daratumumab,talquetamab,teclistamab,pomalidomide
janssen,genmab
['trimm-2', 'multiple #myeloma', 'daratumumab', 'talquetamab']
#asco23 et al presents phase 2 trial results for talquetamab + daratumumab in patients with relapsed/refractory multiple #myeloma: updated trimm-2 results 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.